Advanced Medical Solutions Group (LON:AMS) Shares Pass Below 200 Day Moving Average – Here’s Why

Posted by ABMN Staff on Jun 5th, 2026

Shares of Advanced Medical Solutions Group plc (LON:AMS – Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 216.63 and traded as low as GBX 210. Advanced Medical Solutions Group shares last traded at GBX 217, with a volume of 875,326 shares.

Analyst Ratings Changes

A number of analysts have issued reports on AMS shares. Berenberg Bank reissued a “buy” rating and issued a GBX 300 target price on shares of Advanced Medical Solutions Group in a research report on Tuesday, May 19th. Royal Bank Of Canada reiterated a “sector perform” rating and set a GBX 260 price target on shares of Advanced Medical Solutions Group in a research note on Thursday, April 9th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, Advanced Medical Solutions Group presently has an average rating of “Moderate Buy” and a consensus target price of GBX 270.25.

Check Out Our Latest Research Report on Advanced Medical Solutions Group

Advanced Medical Solutions Group Stock Performance

The firm has a market capitalization of £478.30 million, a PE ratio of 48.78, a PEG ratio of 5.00 and a beta of 0.72. The company has a quick ratio of 4.58, a current ratio of 2.79 and a debt-to-equity ratio of 31.50. The company has a 50-day moving average of GBX 224.16 and a 200 day moving average of GBX 216.63.

Advanced Medical Solutions Group (LON:AMS – Get Free Report) last posted its quarterly earnings data on Wednesday, March 18th. The company reported GBX 11.98 earnings per share for the quarter. Advanced Medical Solutions Group had a net margin of 4.35% and a return on equity of 3.87%. Equities research analysts predict that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current year.

About Advanced Medical Solutions Group

(Get Free Report)

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.